Literature DB >> 19175872

Reverse genetic analysis of a putative, influenza virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus.

Z Meshkat1, M Audsley, C Beyer, E J Gowans, G Haqshenas.   

Abstract

SUMMARY: The p7 protein of hepatitis C virus (HCV) has been classified into a family of viral proteins, designated viroporins that form ion channels. The M2 protein of influenza virus is the prototype viroporin and encodes a HXXXW motif that constitutes the main functional element of the M2 channels. Alignment of different p7 proteins revealed that a HXXXW sequence (positions 17-21) is also highly conserved among some HCV genotypes. To study the putative HXXXW motif in p7, five mutants of the Japanese fulminant hepatitis 1 strain of HCV that encoded H17A, H17G, H17E, Y21A and Y21W were generated. After transfection of human hepatoma cells with the mutant transcripts, unlike H17A and H17G that produced up to 1 log lower viral titres than wild type, H17E and Y21W showed slightly higher infectivity. In conclusion, this study demonstrated that the HXXXW sequence exists in the p7 proteins of some HCV genotypes and that H17 plays an important role in virus replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175872     DOI: 10.1111/j.1365-2893.2008.01064.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  12 in total

1.  NMR structure and ion channel activity of the p7 protein from hepatitis C virus.

Authors:  Roland Montserret; Nathalie Saint; Christophe Vanbelle; Andrés Gerardo Salvay; Jean-Pierre Simorre; Christine Ebel; Nicolas Sapay; Jean-Guillaume Renisio; Anja Böckmann; Eike Steinmann; Thomas Pietschmann; Jean Dubuisson; Christophe Chipot; François Penin
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

2.  Plugging the holes in hepatitis C virus antiviral therapy.

Authors:  Stephen D C Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

3.  Designing and Development of a DNA Vaccine Based On Structural Proteins of Hepatitis C Virus.

Authors:  Roghayeh Teimourpour; Amineh Sadat Tajani; Vahid Reza Askari; Sina Rostami; Zahra Meshkat
Journal:  Iran J Pathol       Date:  2016

4.  Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.

Authors:  Corine StGelais; Toshana L Foster; Mark Verow; Elizabeth Atkins; Colin W G Fishwick; David Rowlands; Mark Harris; Stephen Griffin
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

5.  Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis.

Authors:  Hamed Gouklani; Rowena A Bull; Claudia Beyer; Fasséli Coulibaly; Eric J Gowans; Heidi E Drummer; Hans J Netter; Peter A White; Gholamreza Haqshenas
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.

Authors:  Eike Steinmann; Thomas Pietschmann
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

7.  Design, Construction and Evaluation of 1a/JFH1 HCV Chimera by Replacing the Intergenotypic Variable Region.

Authors:  Faezeh Ghasemi; Majid Ghayour-Mobarhan; Alireza Pasdar; Hamid Pourianfar; Mohammad Reza Aghasadeghi; Hamed Gouklani; Zahra Meshkat
Journal:  Hepat Mon       Date:  2016-08-07       Impact factor: 0.660

Review 8.  A Review of Functional Motifs Utilized by Viruses.

Authors:  Haitham Sobhy
Journal:  Proteomes       Date:  2016-01-21

Review 9.  Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin.

Authors:  Vanesa Madan; Ralf Bartenschlager
Journal:  Viruses       Date:  2015-08-06       Impact factor: 5.048

10.  The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production.

Authors:  Margaret A Scull; William M Schneider; Brenna R Flatley; Robert Hayden; Canny Fung; Christopher T Jones; Marieke van de Belt; François Penin; Charles M Rice
Journal:  PLoS Pathog       Date:  2015-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.